中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2013年
36期
339-340
,共2页
晚期宫颈癌%恩度%化疗
晚期宮頸癌%恩度%化療
만기궁경암%은도%화료
Advanced cervical cancer%Endostar%Chemotherapy
目的：探讨晚期宫颈癌应用恩度联合化疗的价值探讨。方法分析2011年3月至2013年3月我科收治的78例晚期宫颈癌患者，随机分为治疗组与对照组，每组各39例，观察两组的临床治疗效果。结果治疗组的总有效率（30.8%）明显高于对照组的总有效率（17.9%），两组间的总有效率具有统计学意义（χ2=5.228，P=0.023）。结论应用恩度联合化疗方案要由于单用化疗方案，可以改善晚期宫颈癌患者的临床症状，提高临床治疗效果。
目的：探討晚期宮頸癌應用恩度聯閤化療的價值探討。方法分析2011年3月至2013年3月我科收治的78例晚期宮頸癌患者，隨機分為治療組與對照組，每組各39例，觀察兩組的臨床治療效果。結果治療組的總有效率（30.8%）明顯高于對照組的總有效率（17.9%），兩組間的總有效率具有統計學意義（χ2=5.228，P=0.023）。結論應用恩度聯閤化療方案要由于單用化療方案，可以改善晚期宮頸癌患者的臨床癥狀，提高臨床治療效果。
목적：탐토만기궁경암응용은도연합화료적개치탐토。방법분석2011년3월지2013년3월아과수치적78례만기궁경암환자，수궤분위치료조여대조조，매조각39례，관찰량조적림상치료효과。결과치료조적총유효솔（30.8%）명현고우대조조적총유효솔（17.9%），량조간적총유효솔구유통계학의의（χ2=5.228，P=0.023）。결론응용은도연합화료방안요유우단용화료방안，가이개선만기궁경암환자적림상증상，제고림상치료효과。
Objective To investigate the endostatin and the value of chemotherapy for advanced cervical cancer. Methods Analysis from March 2011 to March 2013 our department treated 78 patients with advanced cervical cancer patients were randomly divided into treatment group and control group, 39 cases in each group were observed clinical effect. Results The total efficiency of the treatment group (30.8%) was significantly higher than the total efficiency (17.9%), total effective rate between the two groups was statistically significant (χ2=5.228, P=0.023). Conclusion Application endostar chemotherapy regimens due to chemotherapy alone, in patients with advanced cervical cancer can improve the clinical symptoms, improve clinical outcomes.
